DALRD3

Across TCGA pan-cancer cohorts, DALRD3 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated DALRD3 data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher DALRD3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated DALRD3 expression acts as an unfavorable survival marker, although some lineages such as UCEC and HNSC show a favorable association.

UCEC, HNSC, and GBM are the cancer types where DALRD3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	III,IV	1.000	0.350	.013	32	view →
HNSC	DFS	Quartile	III,IV	1.000	0.643	.009	19	view →
GBM	OS	Quartile	All	0.565	0.374	.015	8	view →
LUAD	DFS	Tertile	All	0.500	0.799	.014	6	view →
CCRCC	DFS	Median	III,IV	0.198	0.887	.010	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

DALRD3–UCEC (DFS)

Open the UCEC breakdown →